I In nt te er rn na at ti io on na al l s st tu ud dy y o of f a as st th hm ma a a an nd d a al ll le er rg gi ie es s i in n c ch hi il ld dh ho oo od d ( (I ISIts specific aims are: 1) to describe the prevalence and severity of asthma, rhinitis and eczema in children living in different centres, and to make comparisons within and between countries; 2) to obtain baseline measures for assessment of future trends in the prevalence and severity of these diseases; and 3) to provide a framework for further aetiological research into genetic, lifestyle, environmental, and medical care factors affecting these diseases.The ISAAC design comprises three phases. Phase 1 uses core questionnaires designed to assess the prevalence and severity of asthma and allergic disease in defined populations. Phase 2 will investigate possible aetiological factors, particularly those suggested by the findings of Phase 1. Phase 3 will be a repetition of Phase 1 to assess trends in prevalence.
Objectives-To compare the prevalence of asthma and allergic disorders among children in Munich, western Germany, and Leipzig, eastern Germany, where environmental exposure, particularly air concentrations of sulphur dioxide and particulate matter, and living conditions have differed over the past 45 years.Design-Prevalence surveys among schoolchildren aged 9-11 years in Leipzig and Munich. Self completion of written questionnaire by the children's parents and lung function measurements.Subjects
Living conditions in eastern Germany have changed rapidly since unification in 1990 and little is known about how these changes affect the prevalence of atopic diseases. This study describes methods and prevalences of a large epidemiological project investigating determinants of childhood asthma and allergies in eastern (Dresden and Leipzig) and western (Munich) Germany in 1995/1996.Community based random samples of 9±11 yr old children in Dresden (n=3,017) and Munich (n=2,612), and of 5±7 yr old children in Dresden (n=3,300), Leipzig (n=3,167) and Munich (n=2,165) were studied by parental questionnaires, bronchial challenges with hypertonic saline, skin examination, skin-prick tests, and measurements of specific and total serum immunoglobulin (Ig)E using Phase II modules of the International Study of Asthma and Allergies in Childhood (ISAAC).In 9±11 yr old children, the prevalence of physician diagnosed asthma (7.9% versus 10.3%; p<0.01) and bronchial hyperresponsiveness (15.7% versus 19.9%; p<0.05) was lower in Dresden than in Munich. No difference between Munich and Dresden was observed in the prevalence of diagnosed hay fever, skin test reactivity to $1 allergen, and increased levels (>0.35 kU . L -1 ) of specific IgE against inhalant and food allergens. Symptoms and visible signs of atopic eczema tended to be more prevalent in Dresden. Similar East-West differences between the three study areas were seen in the younger age group.These findings are in line with recently observed increases in the prevalence of hay fever and atopic sensitization, but not of asthma and bronchial hyperresponsiveness, among 9±11 yr old children in Leipzig.
Background-An ecological analysis was conducted of the relationship between tuberculosis notification rates and the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema in 85 centres from 23 countries in which standardised data are available. These essentially comprised countries in Europe as well as the USA, Canada, Australia, and New Zealand. Methods-Tuberculosis notification rates were obtained from the World Health Organization. Data on the prevalence of symptoms of asthma, rhinitis, and eczema in 235 477 children aged 13-14 years were based on the responses to the written and video questionnaires from the International Study of Asthma and Allergies in Childhood (ISAAC). The analysis was adjusted for gross national product (GNP) as an estimate of the level of aZuence. Results-Tuberculosis notification rates were significantly inversely associated with the lifetime prevalence of wheeze and asthma and the 12 month period prevalence of wheeze at rest as assessed by the video questionnaire. An increase in the tuberculosis notification rates of 25 per 100 000 was associated with an absolute decrease in the prevalence of wheeze ever of 4.7%. Symptoms of allergic rhinoconjunctivitis in the past 12 months were inversely associated with tuberculosis notification rates, but there were no other significant associations with other ISAAC questions on allergic rhinoconjunctivitis or atopic eczema. Conclusions-These findings are consistent with recent experimental evidence which suggests that exposure to Mycobacterium tuberculosis may reduce the risk of developing asthma. (Thorax 2000;55:449-453)
Asthma is common in urban centres in Latin America, but atopic asthma may not be the main phenotype among children. Helminth infections are highly prevalent in poor populations, and it was hypothesised that they attenuate allergic asthma, whereas other factors are related to the expression of a nonatopic wheeze/asthma phenotype.A total of 1,982 children from Southern Brazil with a mean¡SD age of 10.1¡0.76 yrs completed asthma questionnaires, and 1,011 were evaluated for intestinal parasites and atopy using skinprick tests (SPTs).Wheeze in the previous 12 months was reported by 25.6%, and 9.3% showed current asthma; 13% were SPT-positive and 19.1% were positive for any helminths. Most children with either wheeze or asthma were SPT-negative; however, severe wheeze was more prevalent among the atopic minority. Helminth infections were inversely associated with positive SPT results. Bronchiolitis before the age of 2 yrs was the major independent risk factor for asthma at age 10 yrs; high-load Ascaris infection, a family history of asthma and positive SPT results were also asthma risk factors.Most asthma and wheeze are of the nonatopic phenotype, suggesting that some helminths may exert an attenuating effect on the expression of the atopic portion of the disease, whereas viral bronchiolitis predisposes more specifically to recurrent airway symptoms.KEYWORDS: Allergy, bronchiolitis, helminths, intestinal parasites, nonatopic asthma, wheeze T he increased burden and prevalence of wheeze and asthma since the 1960s are well documented, especially among children living in affluent societies [1]. Asthma in school-age children from developed countries is commonly associated with an atopic phenotype, including bronchial hyperresponsiveness, peripheral blood eosinophilia, increased allergenspecific immunoglobulin (Ig)E levels and positive allergen skin-prick test (SPT) results [2,3]. The International Study of Asthma and Allergies in Childhood (ISAAC) has demonstrated that asthma and asthma-related symptoms are highly prevalent among many of the less-privileged communities in Latin America [4]. These data are seemingly at odds with the so-called hygiene hypothesis, and suggest that the relationship between asthma and the atopic phenotype is less clear in children from developing countries. Data from Africa show that the association of asthma with atopy is stronger in children living in urban rather than rural settings [5].Parasitic infections are common among disadvantaged populations in Africa and Latin America. Recent data from these areas have shown an inverse association between helminth infections and allergy (defined by SPT), and probably an attenuation of asthma-related symptoms [6,7]. A series of studies in rural Ecuador have shown that asthma is not common in a highly parasitised population, and that helminth infections are inversely related to allergen skin test reactivity [8]. This raises the question as to which environmental factors might be responsible for the high prevalence of asthma and asthma-relat...
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.